Stay updated with breaking news from Trinetx Diamond Network. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pitavastatin, an FDA-approved statin, may inhibit pathways that contribute to IL-33 production, which has been shown to contribute to cancer development.
Short- or long-term use of opioids may increase risk of poor outcomes in patients with inflammatory bowel disease (IBD), according to investigators.
The presence of autoimmune disease did not appear to increase mortality risk in patients with cancer treated with immune checkpoint inhibitors.